BCM
BRLI

Bridgeway Capital Management’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bridgeway Capital Management’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-85,900
Closed -$3.54M – 1594
2015
Q2 		$3.54M Hold
85,900
– – 0.07% 311
2015
Q1 		$3.03M Buy
+85,900
New +$2.91M 0.06% 371
2014
Q1 		– Sell
-15,500
Closed -$396K – 1499
2013
Q4 		$396K Hold
15,500
– – 0.01% 1140
2013
Q3 		$463K Hold
15,500
– – 0.02% 1078
2013
Q2 		$446K Buy
+15,500
New +$427K 0.02% 996

Other funds holding BRLI

SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Bridgeway Capital Management's BRLI Position: Q3 2015 in Review

Bridgeway Capital Management sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 85,900 shares — an estimated $3.54M sold.

Bridgeway Capital Management first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $3.54M in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • Bridgeway Capital Management reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • Bridgeway Capital Management sold 85,900 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $3.54M.
  • Bridgeway Capital Management first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
  • Bridgeway Capital Management's BIO-REFERENCE LABS INC-NEW- position peaked at $3.54M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on Bridgeway Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.